Home » FDA APPROVES ABIOMED'S IDE FOR IMPELLA 5.0 MINIMALLY INVASIVE CARDIAC SUPPORT SYSTEMS
FDA APPROVES ABIOMED'S IDE FOR IMPELLA 5.0 MINIMALLY INVASIVE CARDIAC SUPPORT SYSTEMS
Abiomed, Inc. today announced conditionalapproval by the U.S. Food and Drug Administration (FDA) of itsInvestigational Device Exemption (IDE) for the IMPELLA 5.0 unique,catheter-based Circulatory Support
Systems. Clinical trials in theU.S. are to begin immediately.
Finanzen.net
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct